-
Je něco špatně v tomto záznamu ?
The Pharmaceutical Ability of Pistacia lentiscus L. Leaves Essential Oil Against Periodontal Bacteria and Candida sp. and Its Anti-Inflammatory Potential
E. Milia, M. Usai, B. Szotáková, M. Elstnerová, V. Králová, G. D'hallewin, Y. Spissu, A. Barberis, M. Marchetti, A. Bortone, V. Campanella, G. Mastandrea, L. Langhansová, S. Eick,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
PubMed Central od 2012
Europe PubMed Central od 2012
ProQuest Central od 2012-01-01
Open Access Digital Library od 2012-01-01
Open Access Digital Library od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources od 2012
Odkazy
PubMed
32466371
DOI
10.3390/antibiotics9060281
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Given the increasing request for natural pharmacological molecules, this study assessed the antimicrobial capacity of Pistacia lentiscus L. essential oil (PLL-EO) obtained from the leaves of wild plants growing in North Sardinia (Italy) toward a wide range of periodontal bacteria and Candida, including laboratory and clinical isolates sp., together with its anti-inflammatory activity and safety. METHODS: PLL-EO was screened by gas chromatography/mass spectrometry. The minimal inhibitory concentration (MIC) was determined. The anti-inflammatory activity was measured by cyclooxygenase (COX-1/2) and lipoxygenase (LOX) inhibition, while the antioxidant capacity was determined electro-chemically and by the MTT assay. The WST-1 assay was used to ascertain cytotoxicity toward four lines of oral cells. RESULTS: According to the concentrations of terpens, PLL-EO is a pharmacologically-active phytocomplex. MICs against periodontal bacteria ranged between 3.13 and 12.5 µg/ml, while against Candida sp. they were between 6.25 and 12.5 µg/mL. Oxidation by COX-1/2 and LOX was inhibited by 80% and 20% µg/mL of the oil, respectively. Antioxidant activity seemed negligible, and no cytotoxicity arose. CONCLUSIONS: PLL-EO exhibits a broad-spectrum activity against periodontal bacteria and Candida, with an interesting dual inhibitory capacity toward COX-2 and LOX inflammatory enzymes, and without side effects against oral cells.
Dental Unite Department of Surgery Azienda Ospedaliero Universitaria 07100 Sassari Italy
Department of Biomedical Science University of Sassari Viale San Pietro 43 C 07100 Sassari Italy
Department of Chemistry and Pharmacy University of Sassari Via Rolando 07100 Sassari Italy
Department of Clinical and Translational Medicine University of Rome Tor Vergata 00133 Rome Italy
Faculty of Medicine Charles University Šimkova 870 50003 Hradec Králové Czech Republic
Institute of Experimental Botany Czech Academy of Sciences Rozvojová 263 16502 Prague Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20019138
- 003
- CZ-PrNML
- 005
- 20201123124054.0
- 007
- ta
- 008
- 201103s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/antibiotics9060281 $2 doi
- 035 __
- $a (PubMed)32466371
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Milia, Egle $u Surgery and Experimental Science, Department of Medicine, University of Sassari, Viale San Pietro 43, 07100 Sassari, Italy.
- 245 14
- $a The Pharmaceutical Ability of Pistacia lentiscus L. Leaves Essential Oil Against Periodontal Bacteria and Candida sp. and Its Anti-Inflammatory Potential / $c E. Milia, M. Usai, B. Szotáková, M. Elstnerová, V. Králová, G. D'hallewin, Y. Spissu, A. Barberis, M. Marchetti, A. Bortone, V. Campanella, G. Mastandrea, L. Langhansová, S. Eick,
- 520 9_
- $a BACKGROUND: Given the increasing request for natural pharmacological molecules, this study assessed the antimicrobial capacity of Pistacia lentiscus L. essential oil (PLL-EO) obtained from the leaves of wild plants growing in North Sardinia (Italy) toward a wide range of periodontal bacteria and Candida, including laboratory and clinical isolates sp., together with its anti-inflammatory activity and safety. METHODS: PLL-EO was screened by gas chromatography/mass spectrometry. The minimal inhibitory concentration (MIC) was determined. The anti-inflammatory activity was measured by cyclooxygenase (COX-1/2) and lipoxygenase (LOX) inhibition, while the antioxidant capacity was determined electro-chemically and by the MTT assay. The WST-1 assay was used to ascertain cytotoxicity toward four lines of oral cells. RESULTS: According to the concentrations of terpens, PLL-EO is a pharmacologically-active phytocomplex. MICs against periodontal bacteria ranged between 3.13 and 12.5 µg/ml, while against Candida sp. they were between 6.25 and 12.5 µg/mL. Oxidation by COX-1/2 and LOX was inhibited by 80% and 20% µg/mL of the oil, respectively. Antioxidant activity seemed negligible, and no cytotoxicity arose. CONCLUSIONS: PLL-EO exhibits a broad-spectrum activity against periodontal bacteria and Candida, with an interesting dual inhibitory capacity toward COX-2 and LOX inflammatory enzymes, and without side effects against oral cells.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Usai, Marianna $u Department of Chemistry and Pharmacy, University of Sassari, Via Rolando, 07100 Sassari, Italy.
- 700 1_
- $a Szotáková, Barbora $u Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, 50005 Hradec Králové, Czech Republic.
- 700 1_
- $a Elstnerová, Marie $u Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, 50005 Hradec Králové, Czech Republic.
- 700 1_
- $a Králová, Věra $u Faculty of Medicine, Charles University, Šimkova 870, 50003 Hradec Králové, Czech Republic.
- 700 1_
- $a D'hallewin, Guy $u National Research Council - Institute of Sciences of Food Production, Traversa La Crucca 3, Loc. Baldinca, 07100 Sassari, Italy.
- 700 1_
- $a Spissu, Ylenia $u National Research Council - Institute of Sciences of Food Production, Traversa La Crucca 3, Loc. Baldinca, 07100 Sassari, Italy.
- 700 1_
- $a Barberis, Antonio $u National Research Council - Institute of Sciences of Food Production, Traversa La Crucca 3, Loc. Baldinca, 07100 Sassari, Italy.
- 700 1_
- $a Marchetti, Mauro $u National Research Council - Institute of Biomolecular Chemistry, Traversa La Crucca 3, Loc. Baldinca, 07100 Sassari, Italy.
- 700 1_
- $a Bortone, Antonella $u Dental Unite, Department of Surgery, Azienda Ospedaliero Universitaria, 07100 Sassari, Italy.
- 700 1_
- $a Campanella, Vincenzo $u Department of Clinical and Translational Medicine, University of Rome, Tor Vergata, 00133 Rome, Italy.
- 700 1_
- $a Mastandrea, Giorgio $u Department of Biomedical Science, University of Sassari, Viale San Pietro 43/C, 07100 Sassari, Italy.
- 700 1_
- $a Langhansová, Lenka $u Institute of Experimental Botany, Czech Academy of Sciences, Rozvojová 263, 16502 Prague, Czech Republic.
- 700 1_
- $a Eick, Sigrun $u Department of Periodontology, School of Dental Medicine, University of Bern, Freiburgstrasse 7, 3010 Bern, Switzerland.
- 773 0_
- $w MED00195446 $t Antibiotics (Basel, Switzerland) $x 2079-6382 $g Roč. 9, č. 6 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32466371 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201103 $b ABA008
- 991 __
- $a 20201123124053 $b ABA008
- 999 __
- $a ind $b bmc $g 1585918 $s 1109336
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 9 $c 6 $e 20200526 $i 2079-6382 $m Antibiotics (Basel) $n Antibiotics $x MED00195446
- LZP __
- $a Pubmed-20201103